Zoetis (ZTS) Competitors

Zoetis (NYSE:ZTS) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

Is ZTS or IDXX more profitable?

Zoetis has a net margin of 27.83% compared to IDEXX Laboratories' net margin of 24.41%. IDEXX Laboratories' return on equity of 64.42% beat Zoetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zoetis	27.83%	56.90%	19.54%
IDEXX Laboratories	24.41%	64.42%	29.89%

Do analysts rate ZTS or IDXX?

Zoetis currently has a consensus target price of $202.43, suggesting a potential upside of 35.21%. IDEXX Laboratories has a consensus target price of $644.67, suggesting a potential downside of 1.17%. Given Zoetis' higher probable upside, analysts clearly believe Zoetis is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zoetis	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has better earnings & valuation, ZTS or IDXX?

Zoetis has higher revenue and earnings than IDEXX Laboratories. Zoetis is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zoetis	$9.26B	7.17	$2.49B	$5.81	25.77
IDEXX Laboratories	$3.90B	13.39	$887.87M	$12.01	54.31

Does the media refer more to ZTS or IDXX?

In the previous week, Zoetis had 13 more articles in the media than IDEXX Laboratories. MarketBeat recorded 57 mentions for Zoetis and 44 mentions for IDEXX Laboratories. Zoetis' average media sentiment score of 1.16 beat IDEXX Laboratories' score of 1.05 indicating that Zoetis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zoetis	40 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	28 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in ZTS or IDXX?

92.8% of Zoetis shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 0.2% of Zoetis shares are held by insiders. Comparatively, 1.0% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more risk and volatility, ZTS or IDXX?

Zoetis has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500.

Summary

IDEXX Laboratories beats Zoetis on 10 of the 17 factors compared between the two stocks.